Target : Phase 4 study, assessment of beta blocker interruption after uncomplicated myocardial infarction.

Trial date : 2018

Number of patients : 3700

Source of funding : Public (APHP)

Centers participating : Multicenter national trial

N°NCT : Coming

STATUT